Disease concurrence in type 1 diabetes

1 型糖尿病并发疾病

基本信息

  • 批准号:
    6891279
  • 负责人:
  • 金额:
    $ 10.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-05-01 至 2007-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This research explores the etiology of Type 1 Diabetes (T1D) through study of patterns of disease concurrence, especially with other autoimmune diseases (AD). Disease concurrence--the occurrence in an individual of two or more diseases--is a prominent feature of autoimmunity, and of T1D in particular. In preliminary studies we establish the methods to obtain the first true population based disease concurrence prevalence rates, and of quantifying the extent of disease concurrence patterns, long thought to be a characteristic feature of autoimmune disease. The relationships among ADs actually constitute a constellation of interrelated diseases, and are thought to reflect common underlying causative factors, due to the interplay of genetic environmental (including infectious agents), sex-related and early life conditional factors. Clarification of the relative importance of these factors for T1D can be revealed and quantified by the study of AD concurrence. Statistical analysis of the national population-based Swedish health data bases, including two diabetes registries, the hospitalization discharge registry, the birth registry and the cancer registry, will be used to uncover similarities and contrast in patterns of disease concurrence in T1D. Linkage of individuals across registries will permit an assessment of T1D disease concurrence and influential cofactors such as birth weight. By examining the ADs most subject to hospitalization, overall patterns of pairwise disease concurrence will be defined. Both statistically established excess and deficit concurrence patterns will be informative. Immune, endocrine and prenatal events will supply the functional background for interpreting age of onset, order of disease onset, gender and the relationship of infectious disease effects relative to T1D concurrence.
描述(由申请人提供):本研究通过研究疾病并发模式,特别是与其他自身免疫性疾病(AD)的并发模式,探索1型糖尿病(T1 D)的病因。疾病并发症-在一个个体中发生两种或多种疾病-是自身免疫的一个突出特征,特别是T1 D。在初步研究中,我们建立了获得第一个真实的基于人群的疾病并发症患病率的方法,以及量化疾病并发症模式的程度的方法,长期以来,疾病并发症模式被认为是自身免疫性疾病的特征。AD之间的关系实际上构成了一系列相互关联的疾病,并且被认为反映了共同的潜在致病因素,这是由于遗传环境(包括感染因子),性别相关和早期生活条件因素的相互作用。这些因素对T1 D的相对重要性的澄清可以通过AD并发症的研究来揭示和量化。将对基于全国人群的瑞典健康数据库进行统计分析,包括两个糖尿病登记处、住院出院登记处、出生登记处和癌症登记处,以揭示T1 D疾病并发模式的相似性和对比。登记研究中个体的关联将允许评估T1 D疾病并发症和有影响力的辅助因素,如出生体重。通过检查最常住院的AD,将定义成对疾病并发的总体模式。统计上确定的过剩和赤字并存模式都将提供信息。免疫、内分泌和产前事件将为解释发病年龄、疾病发病顺序、性别和感染性疾病效应与T1 D并发症的关系提供功能背景。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intrauterine death, fetal malformation, and delayed pregnancy in Ljungan virus-infected mice.
Ljungan 病毒感染小鼠的宫内死亡、胎儿畸形和延迟妊娠。
Fetal death persists through recurrent pregnancies in mice following Ljungan virus infection.
小鼠感染永甘病毒后反复怀孕,胎儿死亡现象持续存在。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM KLITZ其他文献

WILLIAM KLITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM KLITZ', 18)}}的其他基金

Disease concurrence in type 1 diabetes
1 型糖尿病并发疾病
  • 批准号:
    6773483
  • 财政年份:
    2004
  • 资助金额:
    $ 10.82万
  • 项目类别:

相似海外基金

Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia
定义诱发胃化生不同亚型的炎症触发因素
  • 批准号:
    10604888
  • 财政年份:
    2023
  • 资助金额:
    $ 10.82万
  • 项目类别:
Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations
伊他替尼治疗具有激活突变的 JAK/STAT 通路疾病的安全性和有效性
  • 批准号:
    10302165
  • 财政年份:
    2021
  • 资助金额:
    $ 10.82万
  • 项目类别:
TASK ORDER 6R - ASTHMA AND RESPIRATORY DISEASE RESEARCH (ARDR)
任务单 6R - 哮喘和呼吸系统疾病研究 (ARDR)
  • 批准号:
    10875258
  • 财政年份:
    2021
  • 资助金额:
    $ 10.82万
  • 项目类别:
Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome
Wiskott-Aldrich 综合征中 R 环介导的基因组不稳定性的机制
  • 批准号:
    10333324
  • 财政年份:
    2020
  • 资助金额:
    $ 10.82万
  • 项目类别:
Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome
Wiskott-Aldrich 综合征中 R 环介导的基因组不稳定性的机制
  • 批准号:
    10576354
  • 财政年份:
    2020
  • 资助金额:
    $ 10.82万
  • 项目类别:
Immune regulation and autism
免疫调节与自闭症
  • 批准号:
    10152381
  • 财政年份:
    2019
  • 资助金额:
    $ 10.82万
  • 项目类别:
Immune regulation and autism
免疫调节与自闭症
  • 批准号:
    10612952
  • 财政年份:
    2019
  • 资助金额:
    $ 10.82万
  • 项目类别:
Immune regulation and autism
免疫调节与自闭症
  • 批准号:
    10402782
  • 财政年份:
    2019
  • 资助金额:
    $ 10.82万
  • 项目类别:
Mechanisms of Combined Immunodeficiency due to DOCK8 Deficiency
DOCK8 缺陷引起的联合免疫缺陷的机制
  • 批准号:
    10238058
  • 财政年份:
    2018
  • 资助金额:
    $ 10.82万
  • 项目类别:
Microbiota Specific T Cell Selection
微生物群特异性 T 细胞选择
  • 批准号:
    10308400
  • 财政年份:
    2018
  • 资助金额:
    $ 10.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了